Vaccine Trials Children
-
{
- All
- News
- Videos
-
New Fridge-Free Vaccine Could Revolutionise Immunisation Access For All
A new thermostable vaccine that does not require refrigeration has shown promising early results in a human trial. If successful, the technology could simplify vaccine delivery worldwide and significantly improve access for rural populations.
-
No More Covid Boosters For Healthy Children, Adult Americans Without New Trials
US regulators will no longer approve Covid booster shots for healthy adults and children without new studies, adding a costly requirement for drugmakers, though they will still be available for millions of high-risk Americans.
-
Pfizer To Seek US Authorisation For 3rd Covid Shot In Children
Pfizer and BioNTech on Thursday announced positive results from a clinical trial on the safety and immune response of a third dose of their Covid vaccine in children aged five through 11, adding they would soon seek regulatory authorization.
-
Infant Covid Vaccine Succeeded In Trial, Says Moderna
US biotech firm Moderna on Wednesday said it was pursuing regulatory approval for its Covid vaccine in children aged six months to six years after the two-shot regimen was found to be safe and produced a strong immune response.
-
Data From Trials On 2-18-Year-Olds Very Encouraging: Covaxin Maker
Bharat Biotech today announced that Covaxin, its whole-virion inactivated COVID-19 vaccine candidate, has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III trials.
-
Covaxin Showed Good Response In Children During Trials: Covid Panel Chief
Covaxin has shown that it has a very good immune response in children in trials, Chairman of India's COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI) Dr NK Arora said on Sunday.
-
Centre's Decision To Vaccinate Children "Unscientific": Senior AIIMS Epidemiologist
A senior epidemiologist at AIIMS who is the principal investigator of Covaxin trials for adults and children at the institute on Sunday termed the Centre's decision to vaccinate children against Covid "unscientific".
-
Bharat Biotech Submits Data On Covid-19 Vaccine Trial In Children
India is turning its focus towards vaccinating children against the coronavirus, having already administered more than 920 million doses to adults among its population of nearly 1.4 billion.
-
Serum Institute Allowed To Enrol 7-11 Year-Olds In Covid Vaccine Trial
The country's drug regulator today allowed vaccine maker Serum Institute to enrol kids aged 7-11 years for its trial of US drugmaker Novavax's COVID-19 vaccine.
-
Paediatric Covaxin: Bharat Biotech Completes Phase 2/3 Trials
Bharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine, Covaxin for use in children under 18 years of age and is expected to submit the data by next week to the DCGI, Chairman and Managing Director of Bharat Biotech, Krishna Ella said.
-
New Fridge-Free Vaccine Could Revolutionise Immunisation Access For All
A new thermostable vaccine that does not require refrigeration has shown promising early results in a human trial. If successful, the technology could simplify vaccine delivery worldwide and significantly improve access for rural populations.
-
No More Covid Boosters For Healthy Children, Adult Americans Without New Trials
US regulators will no longer approve Covid booster shots for healthy adults and children without new studies, adding a costly requirement for drugmakers, though they will still be available for millions of high-risk Americans.
-
Pfizer To Seek US Authorisation For 3rd Covid Shot In Children
Pfizer and BioNTech on Thursday announced positive results from a clinical trial on the safety and immune response of a third dose of their Covid vaccine in children aged five through 11, adding they would soon seek regulatory authorization.
-
Infant Covid Vaccine Succeeded In Trial, Says Moderna
US biotech firm Moderna on Wednesday said it was pursuing regulatory approval for its Covid vaccine in children aged six months to six years after the two-shot regimen was found to be safe and produced a strong immune response.
-
Data From Trials On 2-18-Year-Olds Very Encouraging: Covaxin Maker
Bharat Biotech today announced that Covaxin, its whole-virion inactivated COVID-19 vaccine candidate, has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III trials.
-
Covaxin Showed Good Response In Children During Trials: Covid Panel Chief
Covaxin has shown that it has a very good immune response in children in trials, Chairman of India's COVID-19 Working Group of the National Technical Advisory Group on Immunisation (NTAGI) Dr NK Arora said on Sunday.
-
Centre's Decision To Vaccinate Children "Unscientific": Senior AIIMS Epidemiologist
A senior epidemiologist at AIIMS who is the principal investigator of Covaxin trials for adults and children at the institute on Sunday termed the Centre's decision to vaccinate children against Covid "unscientific".
-
Bharat Biotech Submits Data On Covid-19 Vaccine Trial In Children
India is turning its focus towards vaccinating children against the coronavirus, having already administered more than 920 million doses to adults among its population of nearly 1.4 billion.
-
Serum Institute Allowed To Enrol 7-11 Year-Olds In Covid Vaccine Trial
The country's drug regulator today allowed vaccine maker Serum Institute to enrol kids aged 7-11 years for its trial of US drugmaker Novavax's COVID-19 vaccine.
-
Paediatric Covaxin: Bharat Biotech Completes Phase 2/3 Trials
Bharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine, Covaxin for use in children under 18 years of age and is expected to submit the data by next week to the DCGI, Chairman and Managing Director of Bharat Biotech, Krishna Ella said.
